We treat the whole spectrum of rheumatological conditions including, but not limited to, primary inflammatory arthropathies (like rheumatoid and psoriatic arthritis), gout and crystal arthritis, ankylosing spondylitis, Connective Tissue and auto-immune diseases (unless organ-associated), vasculitis, GCA, difficult to treat or resistant PMR, difficult to treat or resistant osteoporosis.
Individualised care in accordance with the national and regional guidelines, referring for radiology services including x-rays, MRI bone density scans and ultrasound in rheumatology.
These include conventional Disease Modifying Anti-Rheumatic Drugs (DMARDs, also called conventional synthetic DMARDs, ie: csDMARDs), biologic DMARDs (also called bDMARDs), small molecules target-synthetic DMARDs (also called tsDMARDs), any other agents with NICE license for use in the above conditions.
Specialist IV therapies such as Cyclophosphamide, Rituximab, Zoledronic acid, Infliximab, Tocilizumab, Abatacept.
Ultrasound helps in diagnosis and monitoring of inflammatory arthritis (eg. rheumatoid arthritis, psoriatic arthritis, etc.).
The Rheumatology team has dedicated ultrasound units at both Huddersfield Royal Infirmary and Calderdale Royal Hospital sites and ultrasound is routinely used for diagnosis and monitoring (where appropriate) of disease activity.
Dr Sharif is the lead for this service.